140 related articles for article (PubMed ID: 12033373)
1. Block copolymer micelles for the encapsulation and delivery of amphotericin B.
Lavasanifar A; Samuel J; Sattari S; Kwon GS
Pharm Res; 2002 Apr; 19(4):418-22. PubMed ID: 12033373
[TBL] [Abstract][Full Text] [Related]
2. The effect of fatty acid substitution on the in vitro release of amphotericin B from micelles composed of poly(ethylene oxide)-block-poly(N-hexyl stearate-L-aspartamide).
Lavasanifar A; Samuel J; Kwon GS
J Control Release; 2002 Feb; 79(1-3):165-72. PubMed ID: 11853928
[TBL] [Abstract][Full Text] [Related]
3. Micelles self-assembled from poly(ethylene oxide)-block-poly(N-hexyl stearate L-aspartamide) by a solvent evaporation method: effect on the solubilization and haemolytic activity of amphotericin B.
Lavasanifar A; Samuel J; Kwon GS
J Control Release; 2001 Nov; 77(1-2):155-60. PubMed ID: 11689268
[TBL] [Abstract][Full Text] [Related]
4. Relative aggregation state and hemolytic activity of amphotericin B encapsulated by poly(ethylene oxide)-block-poly(N-hexyl-L-aspartamide)-acyl conjugate micelles: effects of acyl chain length.
Adams ML; Kwon GS
J Control Release; 2003 Feb; 87(1-3):23-32. PubMed ID: 12618020
[TBL] [Abstract][Full Text] [Related]
5. Amphotericin B encapsulated in micelles based on poly(ethylene oxide)-block-poly(L-amino acid) derivatives exerts reduced in vitro hemolysis but maintains potent in vivo antifungal activity.
Adams ML; Andes DR; Kwon GS
Biomacromolecules; 2003; 4(3):750-7. PubMed ID: 12741794
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and nephrotoxicity of amphotericin B-incorporated poly(ethylene glycol)-block-poly(N-hexyl stearate l-aspartamide) micelles.
Diezi TA; Takemoto JK; Davies NM; Kwon GS
J Pharm Sci; 2011 Jun; 100(6):2064-70. PubMed ID: 21491436
[TBL] [Abstract][Full Text] [Related]
7. Polymeric micelles for drug delivery: solubilization and haemolytic activity of amphotericin B.
Yu BG; Okano T; Kataoka K; Kwon G
J Control Release; 1998 Apr; 53(1-3):131-6. PubMed ID: 9741920
[TBL] [Abstract][Full Text] [Related]
8. Optimization of the hydrophobic domain in poly(ethylene oxide)-poly(varepsilon-caprolactone) based nano-carriers for the solubilization and delivery of Amphotericin B.
Falamarzian A; Lavasanifar A
Colloids Surf B Biointerfaces; 2010 Nov; 81(1):313-20. PubMed ID: 20674292
[TBL] [Abstract][Full Text] [Related]
9. In vitro dissociation of antifungal efficacy and toxicity for amphotericin B-loaded poly(ethylene oxide)-block-poly(beta benzyl L aspartate) micelles.
Yu BG; Okano T; Kataoka K; Sardari S; Kwon GS
J Control Release; 1998 Dec; 56(1-3):285-91. PubMed ID: 9801451
[TBL] [Abstract][Full Text] [Related]
10. Enhanced stability of PEG-block-poly(N-hexyl stearate l-aspartamide) micelles in the presence of serum proteins.
Diezi TA; Bae Y; Kwon GS
Mol Pharm; 2010 Aug; 7(4):1355-60. PubMed ID: 20575526
[TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization, and evaluation of amphotericin B-loaded MPEG-PCL-g-PEI micelles for local treatment of oral
Zhou L; Zhang P; Chen Z; Cai S; Jing T; Fan H; Mo F; Zhang J; Lin R
Int J Nanomedicine; 2017; 12():4269-4283. PubMed ID: 28652732
[TBL] [Abstract][Full Text] [Related]
12. Spectroscopic investigation of the aggregation state of amphotericin B during loading, freeze-drying, and reconstitution of polymeric micelles.
Adams M; Kwon GS
J Pharm Pharm Sci; 2004 Nov; 7(4):1-6. PubMed ID: 15850542
[TBL] [Abstract][Full Text] [Related]
13. Mixed micellar nanoparticle of amphotericin B and poly styrene-block-poly ethylene oxide reduces nephrotoxicity but retains antifungal activity.
Han K; Miah MA; Shanmugam S; Yong CS; Choi HG; Kim JA; Yoo BK
Arch Pharm Res; 2007 Oct; 30(10):1344-9. PubMed ID: 18038914
[TBL] [Abstract][Full Text] [Related]
14. Linolenic acid-modified methoxy poly (ethylene glycol)-oligochitosan conjugate micelles for encapsulation of amphotericin B.
Song Z; Wen Y; Deng P; Teng F; Zhou F; Xu H; Feng S; Zhu L; Feng R
Carbohydr Polym; 2019 Feb; 205():571-580. PubMed ID: 30446143
[TBL] [Abstract][Full Text] [Related]
15. Design of Micelle Nanocontainers Based on PDMAEMA-b-PCL-b-PDMAEMA Triblock Copolymers for the Encapsulation of Amphotericin B.
Diaz IL; Parra C; Linarez M; Perez LD
AAPS PharmSciTech; 2015 Oct; 16(5):1069-78. PubMed ID: 25669917
[TBL] [Abstract][Full Text] [Related]
16. Development of respirable nanomicelle carriers for delivery of amphotericin B by jet nebulization.
Gilani K; Moazeni E; Ramezanli T; Amini M; Fazeli MR; Jamalifar H
J Pharm Sci; 2011 Jan; 100(1):252-9. PubMed ID: 20602350
[TBL] [Abstract][Full Text] [Related]
17. Linolenic acid-modified MPEG-PEI micelles for encapsulation of amphotericin B.
Xu H; Teng F; Zhou F; Zhu L; Wen Y; Feng R; Song Z
Future Med Chem; 2019 Oct; 11(20):2647-2662. PubMed ID: 31621420
[No Abstract] [Full Text] [Related]
18. Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles.
Moraes Moreira Carraro TC; Altmeyer C; Maissar Khalil N; Mara Mainardes R
J Mycol Med; 2017 Dec; 27(4):519-529. PubMed ID: 28797532
[TBL] [Abstract][Full Text] [Related]
19. Biodegradable functional polycarbonate micelles for controlled release of amphotericin B.
Wang Y; Ke X; Voo ZX; Yap SSL; Yang C; Gao S; Liu S; Venkataraman S; Obuobi SAO; Khara JS; Yang YY; Ee PLR
Acta Biomater; 2016 Dec; 46():211-220. PubMed ID: 27686042
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and Renal Toxicity of Monomeric Amphotericin B in Rats after a Multiple Dose Regimen.
Kang JY; Gao J; Shin DH; Alvarez C; Zhong W; Kwon GS
Pharm Nanotechnol; 2016; 4(1):16-23. PubMed ID: 27774409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]